Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
Phase 1 Completed
21 enrolled 12 charts
sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC
Phase 1 Completed
3 enrolled
BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
Phase 1 Completed
97 enrolled
IO-001
Phase 1 Completed
119 enrolled
INTRO
Phase 1 Completed
11 enrolled
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
Phase 1 Completed
134 enrolled
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Phase 1 Completed
132 enrolled
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
Phase 1 Completed
50 enrolled
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
Phase 1 Completed
143 enrolled
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
Phase 1 Completed
20 enrolled
A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma
Phase 1 Completed
69 enrolled
Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer
Phase 1 Completed
29 enrolled
Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
Phase 1 Completed
60 enrolled 15 charts
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
Phase 1 Completed
24 enrolled
Gene Therapy in Treating Patients With Primary Brain Tumors
Phase 1 Completed
Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Phase 1 Completed
34 enrolled
Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Phase 1 Completed
11 enrolled
Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer
Phase 1 Completed
15 enrolled
Radiation Therapy in Treating Patients With Glioblastoma
Phase 1 Completed
34 enrolled
Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma
Phase 1 Completed
A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT
Phase 1 Completed
27 enrolled 19 charts
Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma
Phase 1 Completed
13 enrolled
Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support
Phase 1 Completed
25 enrolled
Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
Phase 1 Completed
22 enrolled
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
Phase 1 Completed
23 enrolled
A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas
Phase 1 Completed
22 enrolled 12 charts
Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Phase 1 Completed
24 enrolled
Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Phase 1 Completed
Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
Phase 1 Completed
Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
Phase 1 Completed
6 enrolled
Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers
Phase 1 Completed
30 enrolled
Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
Phase 1 Completed
20 enrolled
Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer
Phase 1 Completed
30 enrolled
Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma
Phase 1 Completed
24 enrolled
Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1 Completed
24 enrolled
Chemotherapy With DNA Damaging Agents In Colorectal Cancer
Phase 1 Completed
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
Phase 1 Completed
20 enrolled
Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
Phase 1 Completed
Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC
Phase 1 Completed
15 enrolled